[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1135140A1 - Single-stranded cyclic rna, and method for production thereof - Google Patents

Single-stranded cyclic rna, and method for production thereof

Info

Publication number
HK1135140A1
HK1135140A1 HK10103140.1A HK10103140A HK1135140A1 HK 1135140 A1 HK1135140 A1 HK 1135140A1 HK 10103140 A HK10103140 A HK 10103140A HK 1135140 A1 HK1135140 A1 HK 1135140A1
Authority
HK
Hong Kong
Prior art keywords
production
stranded cyclic
cyclic rna
rna
stranded
Prior art date
Application number
HK10103140.1A
Other languages
English (en)
Inventor
Hiroshi Abe
Yoshihiro Ito
Naoko Abe
Hidekazu Toyobuku
Original Assignee
Riken
Otsuka Pharma Co Ltd
Hayashi Kasei Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken, Otsuka Pharma Co Ltd, Hayashi Kasei Co Ltd filed Critical Riken
Publication of HK1135140A1 publication Critical patent/HK1135140A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0016—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the nucleic acid is delivered as a 'naked' nucleic acid, i.e. not combined with an entity such as a cationic lipid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/532—Closed or circular
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/50—Methods for regulating/modulating their activity
    • C12N2320/51—Methods for regulating/modulating their activity modulating the chemical stability, e.g. nuclease-resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
HK10103140.1A 2007-05-09 2010-03-25 Single-stranded cyclic rna, and method for production thereof HK1135140A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007125045A JP5296328B2 (ja) 2007-05-09 2007-05-09 １本鎖環状ｒｎａおよびその製造方法
PCT/JP2008/058990 WO2008140126A1 (ja) 2007-05-09 2008-05-09 １本鎖環状ｒｎａおよびその製造方法

Publications (1)

Publication Number Publication Date
HK1135140A1 true HK1135140A1 (en) 2010-05-28

Family

ID=40002313

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10103140.1A HK1135140A1 (en) 2007-05-09 2010-03-25 Single-stranded cyclic rna, and method for production thereof

Country Status (26)

Country Link
US (3) US20100137407A1 (xx)
EP (1) EP2143792B1 (xx)
JP (1) JP5296328B2 (xx)
KR (1) KR101525633B1 (xx)
CN (1) CN101679962A (xx)
AR (1) AR072034A1 (xx)
AU (1) AU2008250075B2 (xx)
BR (1) BRPI0811440A2 (xx)
CA (1) CA2685994A1 (xx)
CO (1) CO6241167A2 (xx)
CY (1) CY1115283T1 (xx)
DK (1) DK2143792T3 (xx)
ES (1) ES2446040T3 (xx)
HK (1) HK1135140A1 (xx)
HR (1) HRP20140170T1 (xx)
IL (1) IL201975A (xx)
MX (1) MX2009011101A (xx)
MY (1) MY154495A (xx)
NZ (1) NZ581251A (xx)
PL (1) PL2143792T3 (xx)
PT (1) PT2143792E (xx)
RU (1) RU2523596C2 (xx)
SI (1) SI2143792T1 (xx)
TW (1) TWI468515B (xx)
UA (1) UA101806C2 (xx)
WO (1) WO2008140126A1 (xx)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009102081A1 (ja) * 2008-02-15 2009-08-20 Riken 環状１本鎖核酸複合体およびその製造方法
WO2011143659A2 (en) * 2010-05-14 2011-11-17 Fluidigm Corporation Nucleic acid isolation methods
US8785121B2 (en) 2010-07-08 2014-07-22 Bonac Corporation Single-stranded nucleic acid molecule for controlling gene expression
PT2431466E (pt) 2010-07-08 2016-01-08 Bonac Corp Molécula de ácido nucleico de cadeia simples para controlar a expressão génica
US8691782B2 (en) 2010-08-03 2014-04-08 Bonac Corporation Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CA3162352A1 (en) 2010-10-01 2012-04-05 Modernatx, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
AR083445A1 (es) 2010-10-14 2013-02-27 Univ Mie siARN CONTRA LA FIBROSIS
US9115167B2 (en) * 2011-03-10 2015-08-25 Biomics Biotechnologies Co., Ltd. Multi-targets interfering RNA molecules and their applications
DE12722942T1 (de) 2011-03-31 2021-09-30 Modernatx, Inc. Freisetzung und formulierung von manipulierten nukleinsäuren
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
HUE057725T2 (hu) 2011-10-03 2022-06-28 Modernatx Inc Módosított nukleozidok, nukleotidok és nukleinsavak és ezek felhasználása
WO2013077446A1 (ja) * 2011-11-26 2013-05-30 株式会社ボナック 遺伝子発現制御のための一本鎖核酸分子
RS63244B1 (sr) 2011-12-16 2022-06-30 Modernatx Inc Kompozicije modifikovane mrna
AU2013243950A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
CN104379744A (zh) 2012-05-26 2015-02-25 株式会社博纳克 具有递送功能的基因表达调控用单链核酸分子
ES2921623T3 (es) 2012-11-26 2022-08-30 Modernatx Inc ARN modificado terminalmente
JP6296434B2 (ja) * 2013-01-25 2018-03-20 国立研究開発法人理化学研究所 機能性核酸分子の構築法
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
JP6625521B2 (ja) 2013-05-15 2020-01-08 リボカイン，エルエルシー 環状ｒｎａの細胞内翻訳
EP3041938A1 (en) 2013-09-03 2016-07-13 Moderna Therapeutics, Inc. Circular polynucleotides
CN104419704B (zh) * 2013-09-05 2016-09-14 中国科学院上海生命科学研究院 一种内含子来源环形rna分子及其成环关键核酸序列的应用
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
CN105980401A (zh) 2013-10-03 2016-09-28 现代治疗公司 编码低密度脂蛋白受体的多核苷酸
EP3088524A4 (en) 2013-12-26 2017-08-09 Tokyo Medical University Artificial mimic mirna for controlling gene expression, and use of same
EP3088525A4 (en) 2013-12-27 2017-08-09 Bonac Corporation Artificial match-type mirna for controlling gene expression and use therefor
BR112017013664A2 (pt) 2014-12-27 2018-03-13 Bonac Corporation mirna de tipo natural, composição, métodos para inibir expressão de um gene alvo e para tratar uma doença, e, ácido nucleico de fita simples.
WO2016158809A1 (ja) 2015-03-27 2016-10-06 株式会社ボナック デリバリー機能と遺伝子発現制御能を有する一本鎖核酸分子
CN105063210A (zh) * 2015-08-12 2015-11-18 中国农业科学院北京畜牧兽医研究所 一种环状rna的鉴定方法
CN107557363B (zh) * 2016-06-30 2021-03-12 中国科学院分子细胞科学卓越创新中心 可诱导型siRNA表达载体及其制备和应用
EP3604528A4 (en) 2017-03-31 2021-01-13 Bonac Corporation CYCLIC NUCLEIC ACID MOLECULE HAVING A GENE EXPRESSION CONTROL FUNCTION
ES2942575T3 (es) 2017-04-28 2023-06-02 Kyowa Kirin Co Ltd Derivado de oligonucleótido o sal del mismo
US11756183B2 (en) 2017-06-23 2023-09-12 Cornell University RNA molecules, methods of producing circular RNA, and treatment methods
MX2020002872A (es) * 2017-09-15 2020-10-05 Commw Scient Ind Res Org Moléculas de arn.
CN111201319A (zh) * 2017-10-11 2020-05-26 日东电工株式会社 核酸分子表达的调节
IL275205B1 (en) 2017-12-15 2024-11-01 Flagship Pioneering Innovations Vi Llc Preparations containing circular polyribonucleotides and their uses
CN108251424A (zh) * 2017-12-19 2018-07-06 天利康（天津）科技有限公司 一种单链环状rna和dna及其制备方法和应用
MX2020009556A (es) * 2018-03-30 2020-10-05 Toray Industries Metodo para producir molecula de acido ribonucleico (arn) de hebra unica en horquilla.
MX2020013236A (es) 2018-06-06 2021-02-22 Massachusetts Inst Technology Acido ribonucleico (arn) circular para traduccion en celulas eucariotas.
DK3930676T3 (en) 2019-03-01 2022-10-31 Flagship Pioneering Innovations Vi Llc Polyribonucleotides and cosmetic uses thereof
US20220088049A1 (en) 2019-03-01 2022-03-24 Flagship Pioneering Innovations Vi, Llc Compositions, methods, and kits for delivery of polyribonucleotides
EP3935162A1 (en) 2019-03-04 2022-01-12 Flagship Pioneering Innovations VI, LLC Circular polyribonucleotides and pharmaceutical compositions thereof
JP2022527763A (ja) 2019-03-25 2022-06-06 フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー 修飾環状ポリリボヌクレオチドを含む組成物及びその使用
SG11202112922WA (en) 2019-05-22 2021-12-30 Massachusetts Inst Technology Circular rna compositions and methods
EP3983539A1 (en) 2019-06-14 2022-04-20 Flagship Pioneering Innovations VI, LLC Circular rnas for cellular therapy
KR20220024647A (ko) 2019-06-19 2022-03-03 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 원형 폴리리보뉴클레오티드의 투여 방법
US20220305128A1 (en) 2019-06-19 2022-09-29 Flagship Pioneering Innovations Vi, Llc Compositions comprising circular polyribonucleotides for protein modulation and uses thereof
MX2022006854A (es) 2019-12-04 2022-11-30 Orna Therapeutics Inc Composiciones y metodos de arn circular.
EP4096682A1 (en) 2020-01-29 2022-12-07 Flagship Pioneering Innovations VI, LLC Compositions for translation and methods of use thereof
US20230104113A1 (en) 2020-01-29 2023-04-06 Flagship Pioneering Innovations Vi, Llc Delivery of compositions comprising circular polyribonucleotides
WO2021236952A1 (en) 2020-05-20 2021-11-25 Flagship Pioneering, Inc. Compositions and methods for producing human polyclonal antibodies
MX2022014607A (es) 2020-05-20 2023-03-15 Flagship Pioneering Innovations Vi Llc Composiciones inmunogenicas y usos de las mismas.
IL298362A (en) 2020-05-20 2023-01-01 Flagship Pioneering Innovations Vi Llc Corona virus antigen compositions and their uses
EP4208196A1 (en) 2020-09-03 2023-07-12 Flagship Pioneering Innovations VI, LLC Immunogenic compositions and uses thereof
WO2022191642A1 (ko) 2021-03-10 2022-09-15 알지노믹스 주식회사 자가 환형화 rna 구조체
JP2024531486A (ja) * 2021-08-27 2024-08-29 北京大学 環状ｒｎａを調製するための構築物及び方法
CA3238735A1 (en) 2021-11-24 2023-06-01 Jennifer A. Nelson Immunogenic compositions and their uses
CA3239266A1 (en) 2021-11-24 2023-06-01 Flagship Pioneering Innovations Vi, Llc Coronavirus immunogen compositions and their uses
EP4436983A1 (en) 2021-11-24 2024-10-02 Flagship Pioneering Innovations VI, LLC Varicella-zoster virus immunogen compositions and their uses
MX2024007307A (es) 2021-12-17 2024-08-06 Flagship Pioneering Innovations Vi Llc Métodos de enriquecimiento de arn circular en condiciones desnaturalizantes.
TW202340461A (zh) 2021-12-22 2023-10-16 美商旗艦先鋒創新有限責任公司 用於純化多核糖核苷酸之組成物和方法
MX2024007870A (es) 2021-12-23 2024-08-15 Flagship Pioneering Innovations Vi Llc Polirribonucleotidos circulares que codifican polipeptidos antifusogenicos.
CN115786374B (zh) * 2022-07-06 2023-10-13 广州吉赛生物科技股份有限公司 一种利用鱼腥藻内含子自剪切核酶精准制备环状rna的方法
WO2024097664A1 (en) 2022-10-31 2024-05-10 Flagship Pioneering Innovations Vi, Llc Compositions and methods for purifying polyribonucleotides
CN116694638A (zh) * 2023-02-20 2023-09-05 天津微环生物医药科技有限责任公司 环状核酸应用-miRNA抑制剂
WO2024192420A1 (en) 2023-03-15 2024-09-19 Flagship Pioneering Innovations Vi, Llc Compositions comprising polyribonucleotides and uses thereof
WO2024192422A1 (en) 2023-03-15 2024-09-19 Flagship Pioneering Innovations Vi, Llc Immunogenic compositions and uses thereof
WO2024220625A1 (en) 2023-04-19 2024-10-24 Sail Biomedicines, Inc. Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
WO2024220712A2 (en) 2023-04-19 2024-10-24 Sail Biomedicines, Inc. Vaccine compositions
WO2024220752A2 (en) 2023-04-19 2024-10-24 Sail Biomedicines, Inc. Rna therapeutic compositions
WO2024226621A1 (en) 2023-04-25 2024-10-31 Ginkgo Bioworks, Inc. Novel internal ribosome entry site (ires) and intron sequences

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11137260A (ja) 1997-11-06 1999-05-25 Soyaku Gijutsu Kenkyusho:Kk 抗インフルエンザウイルス環状ダンベル型ｒｎａ−ｄｎａキメラ化合物及び抗インフルエンザウイルス剤
US6210931B1 (en) * 1998-11-30 2001-04-03 The United States Of America As Represented By The Secretary Of Agriculture Ribozyme-mediated synthesis of circular RNA
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
CA2370628A1 (en) * 1999-04-21 2000-10-26 American Home Products Corporation Methods and compositions for inhibiting the function of polynucleotide sequences
WO2003070918A2 (en) * 2002-02-20 2003-08-28 Ribozyme Pharmaceuticals, Incorporated Rna interference by modified short interfering nucleic acid
US20040259247A1 (en) * 2000-12-01 2004-12-23 Thomas Tuschl Rna interference mediating small rna molecules
US20040019001A1 (en) * 2002-02-20 2004-01-29 Mcswiggen James A. RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA
US20090247606A1 (en) * 2001-08-28 2009-10-01 Sirna Therapeutics, Inc. RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
ATE519774T1 (de) * 2002-02-20 2011-08-15 Sirna Therapeutics Inc Durch eine störung der rna vermittelte inhibierung der genexpression des hepatitis c virus (hcv) mit kurzer, störender nukleinsäure (short interfering nucleic acid, sina)
EP1432724A4 (en) 2002-02-20 2006-02-01 Sirna Therapeutics Inc RNA inhibition mediated inhibition of MAP KINASE GENES
EP1499631A4 (en) * 2002-02-20 2006-01-25 Sirna Therapeutics Inc RNA INTERFERENCE-ADMINISTRATIVE INHIBITION OF TGF-BETA AND TGF-BETA-RECEPTOR GENE EXPRESSION WITH SHORT-INTERFERENCE NUCLEIC ACID (SINA)
US7501503B2 (en) * 2002-12-31 2009-03-10 Mcgill University Compositions and methods for inhibiting RNase H activity of retroid reverse transcriptase
WO2005001063A2 (en) * 2003-06-25 2005-01-06 Somagenics, Inc. Polynucleotides capable of target-dependent circularization and topological linkage
US7972816B2 (en) * 2003-08-08 2011-07-05 National Institute Of Advanced Industrial Science And Technology Efficient process for producing dumbbell DNA
US20060051789A1 (en) * 2004-07-01 2006-03-09 Somagenics, Inc. Methods of preparation of gene-specific oligonucleotide libraries and uses thereof

Also Published As

Publication number Publication date
RU2523596C2 (ru) 2014-07-20
US20190292538A1 (en) 2019-09-26
US20100137407A1 (en) 2010-06-03
TWI468515B (zh) 2015-01-11
UA101806C2 (ru) 2013-05-13
CN101679962A (zh) 2010-03-24
AR072034A1 (es) 2010-08-04
US20180073020A1 (en) 2018-03-15
SI2143792T1 (sl) 2014-05-30
KR101525633B1 (ko) 2015-06-03
AU2008250075B2 (en) 2014-06-19
JP5296328B2 (ja) 2013-09-25
JP2008278784A (ja) 2008-11-20
PT2143792E (pt) 2014-04-03
KR20100024407A (ko) 2010-03-05
AU2008250075A1 (en) 2008-11-20
IL201975A0 (en) 2011-08-01
PL2143792T3 (pl) 2014-07-31
WO2008140126A1 (ja) 2008-11-20
NZ581251A (en) 2011-11-25
EP2143792A4 (en) 2011-08-24
MX2009011101A (es) 2009-12-11
HRP20140170T1 (hr) 2014-04-25
ES2446040T3 (es) 2014-03-06
CO6241167A2 (es) 2011-01-20
CA2685994A1 (en) 2008-11-20
EP2143792A1 (en) 2010-01-13
BRPI0811440A2 (pt) 2014-10-21
DK2143792T3 (da) 2014-04-07
EP2143792B1 (en) 2014-01-08
MY154495A (en) 2015-06-30
CY1115283T1 (el) 2017-01-04
TW200909577A (en) 2009-03-01
RU2009145502A (ru) 2011-06-20
IL201975A (en) 2013-12-31

Similar Documents

Publication Publication Date Title
HK1135140A1 (en) Single-stranded cyclic rna, and method for production thereof
EP2256191A4 (en) SINGLE-STRANDED CYCLIC NUCLEIC ACID COMPLEX AND METHOD FOR PRODUCING SAME
IL211441A (en) Variety of endolysin, methods of manufacture and use thereof
EP2253414A4 (en) METHOD OF FORMING A THROUGH HOLE, AND PRODUCT HAVING A THROUGH HOLE
EP2431465A4 (en) METHOD FOR SYNTHESIS OF DOUBLE-STRENGTHED DNA ACCORDING TO AN RNA AND METHOD FOR DNA AMPLIFICATION
EP2067782A4 (en) HETERACENE DERIVATIVE, TETRAHALOTHERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME
HK1258915A1 (zh) 芳基-2-噁唑氰乙基氨基化合物、其製造方法及用法
PL2295563T3 (pl) Beta-amylaza, kodujący ją gen i sposób jej wytwarzania
EP2130909A4 (en) METHOD OF PRODUCING TOOTH AND TOOTH PRODUCED BY THE METHOD
EP2299452A4 (en) Microstructure, and method for production thereof
EP2140937A4 (en) EXTREMELY HEAT-RESISTANT CATALYST AND PROCESS FOR PRODUCTION THEREOF
EP2247528A4 (en) NANOBAUTEIL, NANOBAUTEIL COMPRISING TRANSISTOR, METHOD FOR PRODUCING NANOBAUTEILS AND METHOD FOR PRODUCING TRANSISTORS
EG25941A (en) Security paper, production method thereof and security documentation produced form same
EP2377926A4 (en) CHONDROCYTE TYPE CELL, AND PROCESS FOR PRODUCING THE SAME
EP2454950A4 (en) ONION EXTRACT AND MANUFACTURING METHOD THEREFOR
EP2159283A4 (en) ROSE CONTAINING A FLAVONE AND METHOD FOR PRODUCING THE SAME
EP2363466A4 (en) TANNASE, ENCODING GENE AND PRODUCTION METHOD THEREOF
EP2412436A4 (en) PROCESS FOR PRODUCING ELECTRODE CATALYST, AND ELECTRODE CATALYST
EP2157072A4 (en) PROCESS FOR THE PREPARATION OF ISOPRENE
IL214362A0 (en) Method for producing hydroxymethyl diphenyloxiranes and corresponding 1-azolylmethyl-1,2-diphenyloxiranes
EP2206751A4 (en) Dyeing Composition, Method for Preparing and Dyeing Method
EP2368705A4 (en) PROCESS FOR PREPARING A BAG AND BAG
EP2290725A4 (en) ORGANIC ELECTROLUMINESCENE ELEMENT AND METHOD FOR THE PRODUCTION THEREOF
EP2364955A4 (en) NITRATE ELIMINATING BIOREACTOR, METHOD FOR FORMING NITRATE ELIMINATING BIOFILM, AND METHOD FOR REMOVING NITRATES
EP2327789A4 (en) NEW COMPOUND SIGNAMYCIN, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180509